variant allele frequency in patients with sf3b1-mutated mds
Published 7 months ago • 129 plays • Length 3:46Download video MP4
Download video MP3
Similar videos
-
2:23
the significance of variant allele frequency in patients with sf3b1-mutated mds
-
2:34
sf3b1-mutant mds: a new disease subtype
-
2:24
sf3b1 mutant mds
-
1:28
assaying flt3 variant allele frequency in aml to determine response to treatment
-
2:12
allosct for aml with mds-related features as per the icc and who 2022 classifications
-
37:37
chemical characterization: how to initiate the biological evaluation of medical devices
-
11:11
3m | molecular detection system (mds) | how to use
-
3:18
midiagnostics' complete blood count (cbc) - blood analysis for diagnosis and monitoring
-
2:10
the impact of sf3b1 mutation in myelofibrosis
-
2:44
bmt ctn 1506/morpho: flt3-itd variant allele frequency and mrd data
-
1:41
an overview of the mds diagnosis pathway
-
3:10
the role of ngs in mds diagnosis
-
3:08
sf3b1 mutation and atm deletion co-drive leukemogenesis through centromeric r-loop dysregulation
-
5:38
the molecular and clinical classifications of mds
-
1:54
fusion-aml-001: molecular changes associated with azacitidine & durvalumab in tp53m aml and hr-mds
-
1:52
advances in lr-mds and hr-mds in 2023 and beyond
-
2:07
the clearance of driver mutations following allosct impacts myelofibrosis disease outcomes
-
4:32
recent advances in the treatment of lr-mds: commands and imerge trial data
-
1:36
clinical trials evaluating novel agents in mds: select-mds-1
-
1:04
mp0533, a cd3-engaging darpin, in r/r aml or mds/aml: preliminary results of a phase i/iia trial
-
2:10
using the innate immune system to treat mds & the value of novel immunotherapies